Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-075854

Options or other derivatives

  • Chief Regulatory Officer acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Puri Raj K. · Chief Regulatory Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-16 Grant or award : show line 1 in the form Restricted Stock Units +15,000 15,000 D
Loading xslF345X06/tm2618145-1_4seq1.xml…